| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1046787691 |
| P356 | DOI | 10.2165/00003088-199834020-00002 |
| P698 | PubMed publication ID | 9515184 |
| P2093 | author name string | Davies NM | |
| P2860 | cites work | Simultaneous determination of codeine and ibuprofen in plasma by high-performance liquid chromatography | Q79986832 |
| The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy | Q93511321 | ||
| Ibuprofen disposition in obese individuals | Q93629558 | ||
| Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine | Q93645828 | ||
| Improved high-performance liquid chromatographic assay of ibuprofen in plasma | Q93672796 | ||
| Concentration of ibuprofen in cervical mucus | Q28322582 | ||
| Isomeric inversion of ibuprofen (R)-enantiomer in humans | Q28342038 | ||
| Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A | Q33969728 | ||
| Ibuprofen overdose: 126 cases | Q34190315 | ||
| A prospective, population-based study of acute ibuprofen overdose: complications are rare and routine serum levels not warranted | Q34212741 | ||
| Etodolac clinical pharmacokinetics | Q34328918 | ||
| Stereoselective disposition of ibuprofen enantiomers in infants | Q34346233 | ||
| The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid | Q34346269 | ||
| Stereoselective disposition of ibuprofen in patients with compromised renal haemodynamics | Q34347126 | ||
| Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid | Q34347422 | ||
| Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans | Q34347616 | ||
| The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac | Q34357985 | ||
| The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons | Q34376740 | ||
| Biliary elimination of non-steroidal anti-inflammatory drugs in patients | Q34398175 | ||
| Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis | Q34403797 | ||
| Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen | Q34421900 | ||
| Clinical pharmacokinetics of tiaprofenic acid and its enantiomers | Q34423057 | ||
| The aspirin-ibuprofen interaction in rheumatoid arthritis | Q34518170 | ||
| Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid | Q34543307 | ||
| Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen | Q34560085 | ||
| The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis | Q34561120 | ||
| Stereoselective disposition of ibuprofen enantiomers in man | Q34622724 | ||
| Interaction of ibuprofen and warfarin on primary haemostasis | Q34679709 | ||
| Anti-inflammatory agents: determination of ibuproxam and its metabolite humans. Correlation between bioavailability, tolerance and chemico-physical characteristics. | Q34716274 | ||
| Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen | Q34732653 | ||
| Metabolic stereoisomeric inversion of ibuprofen in mammals | Q34791840 | ||
| Clinical pharmacokinetics of ketorolac tromethamine | Q35572364 | ||
| Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs | Q36072046 | ||
| Enantiospecific determination of ibuprofen in rat plasma using chiral fluorescence derivatization reagent, (-)-2-[4-(1-aminoethyl)phenyl]-6- methoxybenzoxazole | Q36711275 | ||
| Toxicological detection of ibuprofen and its metabolites in urine using gas chromatography-mass spectrometry (GC-MS). | Q36748870 | ||
| Design of crossover microcomputer program and application on drug bioequivalence data | Q36833307 | ||
| Stereoselective metabolism of anti-inflammatory 2-arylpropionates | Q37946469 | ||
| Stereoselective plasma protein binding of ibuprofen enantiomers | Q45720989 | ||
| Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men. | Q45880220 | ||
| The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen | Q46155446 | ||
| Some biological properties of 2-(4-isobutylphenyl)-propionic acid | Q46834445 | ||
| Development and validation of a liquid chromatographic method for the quantitation of ibuprofen enantiomers in human plasma | Q47339346 | ||
| Isolation and characterization of rat liver microsomal R-ibuprofenoyl-CoA synthetase. | Q50535210 | ||
| Effect of high-dose ibuprofen in patients with cystic fibrosis. | Q50594133 | ||
| Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals. | Q51575358 | ||
| The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. | Q51580189 | ||
| Comparative bioavailability of two tablet formulations of ibuprofen. | Q51589071 | ||
| Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam. | Q51740563 | ||
| The effect of octanoic acid on the binding of the enantiomers of ibuprofen and naproxen to human serum albumin: a chromatographic implication. | Q52319770 | ||
| [Drug release kinetics of ibuprofen coated granules and their in vitro-in vivo correlation]. | Q52420403 | ||
| The Relationship between Plasma Ibuprofen Concentrations and Toxicity in Acute Ibuprofen Overdose | Q52426605 | ||
| Pharmacokinetics of ibuprofen in man--III: Plasma protein binding. | Q52433068 | ||
| An evaluation of ibuprofen bioinversion by simulation | Q52465040 | ||
| Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs. | Q52573375 | ||
| Ultrafiltration in serum protein binding determinations. | Q52741549 | ||
| A study on the effects of ibuprofen on the metabolism of antipyrine in man. | Q53758506 | ||
| Stereoselective disposition of ibuprofen and flurbiprofen in rats. | Q54101304 | ||
| The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. | Q54140545 | ||
| Solid-phase extraction chromatography and nuclear magnetic resonance spectrometry for the identification and isolation of drug metabolites in urine. | Q54558919 | ||
| Lack of ibuprofen secretion into human milk. | Q55063009 | ||
| Effects of pH regulators used as additives on the bioavailability of ibuprofen from hard gelatin capsules | Q57226686 | ||
| Pharmacokinetics Of Ibuprofen Enantiomers In Plasma And Suction Blister Fluid In Healthy Volunteers | Q57415339 | ||
| Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs—II Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters | Q57415346 | ||
| The stereoselective uptake of ibuprofen enantiomers into adipose tissue | Q57415361 | ||
| Liquid Chromatographic Determination and Plasma Concentration Profile of Optical Isomers of Ibuprofen in Humans | Q57415363 | ||
| Liquid chromatography coupled with high-field proton NMR for profiling human urine for endogenous compounds and drug metabolites | Q58046457 | ||
| [Kinetic studies of ibuprofen on humans. Comparative study for the determination of blood concentrations and metabolites following local and oral administration] | Q58882246 | ||
| Rapid high-performance liquid chromatographic assay for the simultaneous analysis of non-steroidal antiinflammatory drugs in plasma | Q59525077 | ||
| High-performance liquid chromatographic determination of naproxen, ibuprofen and diclofenac in plasma and synovial fluid in man | Q60704945 | ||
| Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis. | Q64885687 | ||
| GLC Determination of Ibuprofen [dl-2-(p-Isobutylphenyl)propionic Acid] Enantiomers in Biological Specimens | Q66959731 | ||
| Rapid determination of ibuprofen in plasma by high-performance liquid chromatography | Q67001557 | ||
| Determination of some anti-inflammatory drugs in serum by high-performance liquid chromatography | Q67004547 | ||
| Binding of nonsteroidal anti-inflammatory agents to proteins—I. Ibuprofen-serum albumin interaction | Q67018378 | ||
| A Simple and Sensitive Colorimetric Determination of Ibuprofen from Plasma and Urine in Dogs after Dosing | Q67054323 | ||
| The metabolism of ibuprofen | Q67267970 | ||
| Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man | Q67285537 | ||
| Electron-Capture GLC Determination of Ibuprofen in Serum | Q67318958 | ||
| Gas-liquid chromatographic determination of ibuprofen in human plasma | Q67340166 | ||
| Studies on the metabolism of 2,4'-isobutylphenylpropionic acid (ibuprofen) by gas chromatography and mass spectrometry. Dialysis fluid, a convenient medium for studies on drug metabolism | Q67342281 | ||
| Concentrations of ibuprofen in serum and synovial fluid from patients with arthritis [proceedings] | Q67427187 | ||
| S(+) versus racemic ibuprofen | Q67514289 | ||
| Lack of interaction between ibuprofen and warfarin | Q67516824 | ||
| Chiral separation by capillary electrophoresis with oligosaccharides | Q67578654 | ||
| Effect of ibuprofen on protein binding of warfarin in human serum | Q67600883 | ||
| Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers | Q67774908 | ||
| Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofen | Q67804258 | ||
| Column-switching techniques for high-performance liquid chromatography of ibuprofen and mefenamic acid in human serum with short-wavelength ultraviolet detection | Q67868831 | ||
| Evaluation of the absorption from three ibuprofen formulations | Q69723735 | ||
| GLC Determination of Ibuprofen [(±)-2-(p-Isobutylphenyl)propionic Acid] in Plasma | Q69737150 | ||
| Rapid HPLC-determination of ibuprofen and flurbiprofen in plasma for therapeutic drug control and pharmacokinetic applications | Q69740152 | ||
| High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids | Q69752292 | ||
| Pharmacological differences between R(-)- and S(+)-ibuprofen | Q69767572 | ||
| [Pharmacokinetic variables under therapy with a nonsteroidal antirheumatic with a short half-life in patients over 65 years old] | Q69804220 | ||
| Antihypertensive activity of enalapril. Effect of ibuprofen and different salt intakes | Q69832119 | ||
| Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen | Q69907387 | ||
| Do nizatidine and cimetidine interact with ibuprofen? | Q69929719 | ||
| The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites | Q70031873 | ||
| Simultaneous liquid-chromatographic determination of five nonsteroidal anti-inflammatory drugs in plasma or blood | Q70049278 | ||
| Ibuprofen: plasma concentrations in man | Q70072295 | ||
| Assay of ibuprofen in human plasma by rapid and sensitive reversed-phase high-performance liquid chromatography:application to a single dose pharmacokinetic study | Q70129431 | ||
| Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects | Q70169948 | ||
| Pharmacokinetics of the R(-) and S(+) enantiomers of ibuprofen in the serum and synovial fluid of arthritis patients | Q70179212 | ||
| Liquid chromatographic determination of the enantiomers of ibuprofen in plasma using a chiral AGP column | Q70199707 | ||
| Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide | Q70200815 | ||
| Silica capillary gas chromatographic determination of ibuprofen in serum | Q70213753 | ||
| Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers | Q70259377 | ||
| Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral alpha 1-acid glycoprotein column | Q70261466 | ||
| [Pharmacokinetics and bioequivalence of two ibuprofen formulations] | Q70290192 | ||
| Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis | Q70334636 | ||
| Effects of age on the clinical pharmacokinetics of ibuprofen | Q70372150 | ||
| Phenytoin toxicity induced by interaction with ibuprofen | Q70464790 | ||
| Liquid chromatographic analysis of carboxylic acids using N-(4-aminobutyl)-N-ethylisoluminol as chemiluminescent label: determination of ibuprofen in saliva | Q70467541 | ||
| Relative bioavailability of commercially available ibuprofen oral dosage forms in humans | Q70485674 | ||
| Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations | Q70490339 | ||
| [Ibuprofen pharmacokinetics in patients with liver cirrhosis] | Q70498590 | ||
| High-performance liquid chromatographic determination of ibuprofen and its major metabolites in biological fluids | Q70544040 | ||
| Screening for acidic and neutral drugs by high performance liquid chromatography in post-mortem blood | Q70595342 | ||
| Absorption and disposition of ibuprofen in the elderly | Q70612534 | ||
| Studies on the oral absorption of ibuprofen guaiacol-ester in man | Q70630235 | ||
| A study of the absorption and tolerance of ibuprofen guaiacol ester in man after repeated oral administration | Q70633733 | ||
| Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans | Q70669399 | ||
| Determination of ibuprofen in capillary and venous plasma by high-performance liquid chromatography with ultraviolet detection | Q70678717 | ||
| Tissue distribution of ibuprofen in a fatal overdose | Q70717375 | ||
| Determination of ibuprofen in human plasma by high-performance liquid chromatography | Q70736805 | ||
| Liquid chromatographic/mass spectrometric determination of optically active drugs | Q70749808 | ||
| Effect of sucralfate on ibuprofen absorption in normal volunteers | Q70817426 | ||
| Pharmacokinetics and bioavailability of percutaneous ibuprofen | Q70986424 | ||
| Determination of ibuprofen in serum by high-performance liquid chromatography and application to ibuprofen disposition | Q71044518 | ||
| 2-Arylpropionyl-CoA epimerase: partial peptide sequences and tissue localization | Q71044774 | ||
| Determination of Flurbiprofen and Ibuprofen in Dog Serum with Automated Sample Preparation | Q71046503 | ||
| Ibuprofen and acetaminophen kinetics when taken concurrently | Q71064713 | ||
| The binding of ibuprofen to plasma proteins | Q71166883 | ||
| Absorption and disposition of ibuprofen in hemodialyzed uremic patients | Q71205871 | ||
| Intrasubject variability in bioequivalence studies illustrated by the example of ibuprofen | Q71212631 | ||
| Quantitation of ibuprofen in biological fluids by gas chromatography--mass spectrometry | Q71242254 | ||
| Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level | Q71401212 | ||
| Determination of ibuprofen by high-performance liquid chromatography | Q71431502 | ||
| The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs | Q71488498 | ||
| Analysis of ibuprofen in serum by capillary electrophoresis | Q71696679 | ||
| The effect of ibuprofen on serum digoxin concentrations | Q71705282 | ||
| Some aspects of the pharmacology, metabolism, and toxicology of ibuprofen. I. Pharmacology and metabolism | Q71711484 | ||
| [Evaluation of drug concentration in tissues after percutaneous administration of non-steroidal antirheumatics] | Q71744670 | ||
| Use of a rapid HPLC assay for determination of pharmacokinetic parameters of ibuprofen in patients with cystic fibrosis | Q71754309 | ||
| Ibuprofen and sulindac kinetics in alcoholic liver disease | Q71761956 | ||
| Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships | Q71761993 | ||
| Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules | Q71781299 | ||
| A rapid extraction method for acidic drugs in hemolyzed blood | Q71835147 | ||
| Influence of age on the stereoselective disposition and metabolism of ibuprofen in humans | Q71883305 | ||
| Taurine conjugation of ibuprofen in humans and in rat liver in vitro. Relationship to metabolic chiral inversion | Q72023073 | ||
| Ibuprofen levels in serum and synovial fluid | Q72024431 | ||
| Pharmacokinetic evaluation of two ibuprofen-codeine combinations | Q72064170 | ||
| High-pressure liquid chromatographic determination of ibuprofen in plasma | Q72090267 | ||
| High-performance liquid chromatographic assay for ibuprofen in whole blood using solid-phase extraction | Q72091275 | ||
| Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin | Q72111493 | ||
| Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment | Q72151517 | ||
| Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? | Q72207216 | ||
| Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A | Q72212182 | ||
| Stereoselective disposition of ibuprofen in patients with renal dysfunction | Q72256589 | ||
| A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs | Q72400716 | ||
| Resolution of the enantiomers of ibuprofen; comparison study of diastereomeric method and chiral stationary phase method | Q72522233 | ||
| The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolic inversion of ibuprofen in healthy subjects | Q72528870 | ||
| Percutaneous absorption of ibuprofen from different formulations. Comparative study with gel, hydrophilic ointment and emulsion cream | Q72547509 | ||
| Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects | Q72578202 | ||
| Stereospecific high-performance liquid chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency | Q72662125 | ||
| Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans | Q72746261 | ||
| Pharmacodynamic modeling of nonsteroidal anti-inflammatory drugs: antipyretic effect of ibuprofen | Q72752639 | ||
| Separation of fifteen non-steroidal anti-inflammatory drugs using micellar electrokinetic capillary chromatography | Q72784007 | ||
| Gas chromatographic-mass spectrometric determination of ibuprofen enantiomers in human plasma using R(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol as derivatizing reagent | Q72874411 | ||
| The effect of colestipol and cholestyramine on ibuprofen bioavailability in man | Q72891504 | ||
| High-performance liquid chromatography coupled to high-field proton nuclear magnetic resonance spectroscopy: application to the urinary metabolites of ibuprofen | Q72951450 | ||
| Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? | Q72988824 | ||
| Comparison of tissue and plasma levels of ibuprofen after oral and topical administration | Q73009079 | ||
| Understanding the chiral pharmacology of nonsteroidal antiinflammatory drugs in the aryl propionic acid class: S(+) ibuprofen. Overview of the symposium "update on S(+) ibuprofen" (Going/Kitzbuehl, Austria, February 2-4, 1996) | Q73024807 | ||
| Physical aspects of dexibuprofen and racemic ibuprofen | Q73024810 | ||
| Ibuprofen enantiomers and lipid metabolism | Q73024824 | ||
| Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration | Q73042072 | ||
| Synthesis, chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: major metabolites of ibuprofen in man | Q73204596 | ||
| High-performance thin-layer chromatographic determination of ibuprofen in plasma | Q73230478 | ||
| Stereoselective disposition of ibuprofen enantiomers in the isolated perfused rat kidney | Q67882543 | ||
| Method to determine the enantiomers of ibuprofen from human urine by high-performance liquid chromatography | Q67931609 | ||
| An alternative approach for assessment of rate of absorption in bioequivalence studies | Q67977677 | ||
| Improved high-performance liquid chromatographic assay method for the enantiomers of ibuprofen | Q67982501 | ||
| Enantiospecific gas chromatographic-mass spectrometric procedure for the determination of ketoprofen and ibuprofen in synovial fluid and plasma: application to protein binding studies | Q67989009 | ||
| Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients | Q67990616 | ||
| Elevation of gastric pH with ranitidine does not affect the release characteristics of sustained release ibuprofen tablets | Q67998369 | ||
| [Comparative biological availability of two different ibuprofen granules] | Q68001788 | ||
| Binding affinity of ibuprofen in human tissues | Q68008887 | ||
| Pharmacokinetics of ibuprofen enantiomers after single and repeated doses in man | Q68009664 | ||
| Determination of ibuprofen in human plasma by high-performance liquid chromatography | Q68014051 | ||
| Determination of ibuprofen and its major metabolites in human urine by high-performance liquid chromatography | Q68014099 | ||
| Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets | Q68036653 | ||
| Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates | Q68064188 | ||
| Further characterization of specific drug binding sites on human serum albumin | Q68217860 | ||
| Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen | Q68232214 | ||
| Bioavailability of three commercial preparations of ibuprofen 600 mg | Q68288632 | ||
| Metabolic inversion of stereoisomeric ibuprofen in man | Q68318465 | ||
| Effect of ranitidine and cimetidine on ibuprofen pharmacokinetics | Q68344768 | ||
| Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids | Q68366476 | ||
| Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison | Q68504271 | ||
| The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans | Q68545112 | ||
| Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis | Q68560414 | ||
| Metabolic stereoisomeric inversion of 2-arylpropionic acids. On the mechanism of ibuprofen epimerization in rats | Q68706547 | ||
| Clinical pharmacology of predisintegrated ibuprofen 800 mg tablets: an endoscopic and pharmacokinetic study | Q68708957 | ||
| A pharmacokinetic comparison of ibuprofen sustained-release tablets given to young and elderly patients | Q68739564 | ||
| Measurement of ibuprofen in human whole blood by reversed-phase ion-paired high-performance liquid chromatography using a pH-stable polymeric column | Q68789114 | ||
| Studies of urinary metabolites of 2-(4-isobutylphenyl) propionic acid by gas-liquid chromatography-mass spectrometry | Q68807256 | ||
| Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of 171Er-labeled sustained-release tablets | Q68853632 | ||
| Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-) p-iso-butyl hydratropic acid | Q68877734 | ||
| High-performance liquid chromatographic determination of the stereoisomeric metabolites of ibuprofen | Q68884051 | ||
| High-performance liquid chromatographic determination of pimeprofen and its metabolite ibuprofen in sheep plasma and lymph | Q68993469 | ||
| Determination of the enantiomeric composition of ibuprofen in human plasma by high-performance liquid chromatography | Q69026230 | ||
| Rapid extraction of anti-inflammatory drugs in whole blood for HPLC analysis | Q69058665 | ||
| [Concentrations of ibuprofen and the protein and pH value of synovial fluid and plasma following oral administration of ibuprofen in patients with arthritis] | Q69392073 | ||
| Rapid high-performance liquid chromatographic methods for the determination of overdose concentrations of some non-steroidal anti-inflammatory drugs in plasma or serum | Q69428492 | ||
| Identification and simultaneous determination of non-steroidal anti-inflammatory drugs using high-performance liquid chromatography | Q69428556 | ||
| High-performance liquid chromatographic determination of ibuprofen in rat and human plasma | Q69448221 | ||
| Tissue levels of ibuprofen after fatal overdosage of ibuprofen and acetaminophen | Q69459506 | ||
| Percutaneous ibuprofen therapy with Trauma-Dolgit gel: bioequivalence studies | Q69469422 | ||
| Rapid high-performance liquid chromatographic determination of ibuprofen in human plasma | Q69517510 | ||
| Pharmacokinetics of two new oral formulations of ibuprofen | Q69570200 | ||
| Gas chromatographic separation of optically active anti-inflammatory 2-arylpropionic acids using (+)- or (-)-amphetamine as derivatizing reagent | Q69571378 | ||
| Development of capillary gas chromatographic-mass spectrometric methodology for the simultaneous determination of ibuprofen and [ar-2H4]ibuprofen in serum: demonstration of kinetic equivalence in the beagle | Q69593291 | ||
| Absorption kinetics of rectally and orally administered ibuprofen | Q69608741 | ||
| Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans | Q69615061 | ||
| Binding affinity of ibuprofen to collagen and other connective tissue components | Q43816266 | ||
| Pharmacokinetics of ibuprofen microincapsulated granules | Q43819696 | ||
| Rapid GLD determination of ibuprofen in serum | Q43886721 | ||
| Intra-uterine pressure and serum ibuprofen: observations after oral administration of 400 mg ibuprofen to a patient with primary dysmenorrhoea | Q44304023 | ||
| Pharmacokinetic and taste evaluation of ibuprofen (Motrin) 800 mg tablets in extemporaneous solution | Q44553151 | ||
| Effects of misoprostol or ranitidine on ibuprofen pharmacokinetics | Q44933074 | ||
| The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide | Q45048202 | ||
| Effect of antacid suspension on the pharmacokinetics of ibuprofen | Q45079819 | ||
| Ibuprofen kinetics in plasma and synovial fluid of arthritic patients | Q45169483 | ||
| High-performance liquid chromatographic determination of ibuprofen in human plasma and urine by direct injection | Q69620847 | ||
| The influence of sucralfate on ibuprofen absorption in healthy adult males | Q69658997 | ||
| Influence of racial differences on effects of ranitidine and cimetidine on ibuprofen pharmacokinetics | Q69664548 | ||
| Isolation and characterization of major phase I and II metabolites of ibuprofen | Q73371193 | ||
| Comparison of the antinociception produced by two oral formulations of ibuprofen: ibuprofen effervescent vs ibuprofen tablets | Q73396430 | ||
| Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers | Q73400824 | ||
| Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction | Q73428170 | ||
| Are the pharmacokinetics of ibuprofen important determinants for the drug's efficacy in postoperative pain after third molar surgery? | Q73486720 | ||
| Analysis of ibuprofen metabolites by semi-microcolumn liquid chromatography with ultraviolet absorption and pulsed amperometric detectors | Q73517519 | ||
| A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and naproxen to human serum albumin | Q73595119 | ||
| Ibuprofen in human milk | Q73647816 | ||
| Determination of ibuprofen in human plasma by solid phase extraction and reversed-phase high-performance liquid chromatography | Q79986827 | ||
| Clinical pharmacokinetics of ketoprofen and its enantiomers | Q37950598 | ||
| Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (—)-isomer | Q39099127 | ||
| The Analgesic Interaction of Misoprostol with Nonsteroidal Anti-Inflammatory Drugs. | Q39466029 | ||
| Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs | Q39549705 | ||
| Excretion of ibuprofen into breast milk | Q39554388 | ||
| The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences | Q39626560 | ||
| Update on ibuprofen: review article | Q39731841 | ||
| Lipophilic xenobiotic conjugates: the pharmacological and toxicological consequences of the participation of drugs and other foreign compounds as substrates in lipid biosynthesis | Q39843876 | ||
| Ibuprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic disorders | Q40006961 | ||
| The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequences | Q40092311 | ||
| Drug kinetics in burn patients | Q40294496 | ||
| Clinical pharmacokinetics of flurbiprofen and its enantiomers | Q40517214 | ||
| Effect of age on ibuprofen pharmacokinetics and antipyretic response | Q40726124 | ||
| Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children | Q40730724 | ||
| Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children | Q40736573 | ||
| Pharmacokinetics of ibuprofen in febrile children | Q40752906 | ||
| Pharmacokinetics of ibuprofen in man: a single-dose comparison of two over-the-counter, 200 mg preparations | Q40761445 | ||
| The pharmacokinetics of ibuprofen after burn injury | Q41062340 | ||
| Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies | Q41075378 | ||
| Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. | Q41100709 | ||
| The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat. | Q41118627 | ||
| Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. | Q41128704 | ||
| Salicylate-NSAID interactions | Q41143601 | ||
| Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--1. In vitro studies of ibuprofen and flurbiprofen | Q41284725 | ||
| Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen | Q41334095 | ||
| Clinical pharmacokinetics of naproxen | Q41440092 | ||
| Methods of analysis of chiral non-steroidal anti-inflammatory drugs | Q41489608 | ||
| Anti-inflammatory (ibuprofen) drug therapy in rheumatoid arthritis- rate of response and lack of time dependency of plasma pharmacokinetics | Q41812514 | ||
| Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen. | Q41814578 | ||
| Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases | Q42008598 | ||
| Renal handling and effects of S(+)-ibuprofen and R(-)-ibuprofen in the rat isolated perfused kidney | Q42011212 | ||
| Pharmacokinetic modelling of ibuprofen | Q42080959 | ||
| Liquid-chromatographic assay of ibuprofen enantiomers in plasma | Q42213474 | ||
| Stereoselective disposition of ibuprofen enantiomers in synovial fluid | Q42213910 | ||
| Pharmacokinetics of ibuprofen | Q42249869 | ||
| Ibuprofen pharmacokinetics: use of liquid chromatography with radial compression separation. | Q42255043 | ||
| Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. | Q42255744 | ||
| High-pressure Liquid Chromatographic Determination of Ibuprofen in Plasma | Q42270415 | ||
| Transsynovial distribution of ibuprofen in arthritic patients | Q42274287 | ||
| Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly | Q42279636 | ||
| Cimetidine does not alter ibuprofen kinetics after a single dose | Q42531575 | ||
| Delirium caused by tacrine and ibuprofen interaction | Q42556416 | ||
| Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant | Q42653192 | ||
| Ibuprofen bio-availability. A comparison of Brufen and Inza | Q42661443 | ||
| Pharmacokinetics of ibuprofen in man IV: absorption and disposition | Q42667079 | ||
| Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients | Q42672511 | ||
| Dose-response study with ibuprofen in rheumatoid arthritis: clinical and pharmacokinetic findings | Q42713139 | ||
| Lack of effect of cimetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen | Q42768668 | ||
| Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro | Q43224600 | ||
| Inability of ibuprofen to alter single dose phenytoin disposition | Q43240385 | ||
| S-ibuprofen versus ibuprofen-racemate. A randomized double-blind study in patients with rheumatoid arthritis | Q43457156 | ||
| Evaluation of ibuprofen dimethyl aminoethanol octyl bromide and related active metabolites in biological samples | Q43505370 | ||
| Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin | Q43593495 | ||
| Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis | Q43685074 | ||
| The correlation between blood levels of ibuprofen and clinical analgesic response | Q43780693 | ||
| P433 | issue | 2 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 101-154 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Clinical pharmacokinetics of ibuprofen. The first 30 years | |
| P478 | volume | 34 |
| Q47555047 | A Pharmacokinetic Study of an Ibuprofen Topical Patch in Healthy Male and Female Adult Volunteers. |
| Q43297764 | A fixed dose combination of ibuprofen and famotidine |
| Q34027088 | A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults |
| Q46342214 | A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testing |
| Q39404060 | A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain |
| Q35996458 | Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised control |
| Q64250047 | Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility |
| Q46653297 | An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies. |
| Q39168414 | Analgesic Efficacy of a New Immediate-Release/Extended-Release Formulation of Ibuprofen: Results From Single- and Multiple-Dose Postsurgical Dental Pain Studies |
| Q50134125 | Antimicrobial Activity of Ibuprofen Against Cystic Fibrosis Associated Gram-Negative Pathogens. |
| Q41820962 | Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds |
| Q40124752 | Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. |
| Q50086889 | Assessing the risk of alcohol-induced dose dumping from sustained-release oral dosage forms: in vitro-in silico approach. |
| Q42170098 | Assessment of enthesitis in patients with psoriatic arthritis using clinical examination and ultrasound |
| Q44010349 | Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations |
| Q33517240 | Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers |
| Q52003016 | Bioavailability prediction based on molecular structure for a diverse series of drugs. |
| Q80378972 | Bioequivalence study of two Ibuprofen formulations administered intravenously in healthy male volunteers |
| Q43287011 | Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers |
| Q85243874 | Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis |
| Q96821199 | Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen |
| Q39190121 | Cholesterol expels ibuprofen from the hydrophobic membrane core and stabilizes lamellar phases in lipid membranes containing ibuprofen |
| Q34756316 | Clinical pharmacokinetics of oxaprozin |
| Q34087882 | Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial |
| Q39411747 | Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen |
| Q35003605 | Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies |
| Q48117508 | Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes. |
| Q43755752 | Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy. |
| Q50896858 | Determination of nonsteroidal anti-inflammatory drugs in human tear and plasma samples using ultra-fast liquid chromatography-tandem mass spectrometry. |
| Q43962361 | Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein |
| Q92186404 | Direct in situ labeling of target drugs with a fluorophore probe to improve MALDI-MS detection sensitivity in micro-liter plasma |
| Q42516504 | Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea-pig gastric mucous cells: inhibition of basal apoptosis by diclofenac |
| Q43327342 | Distinct enantiomeric signals of ibuprofen and naproxen in treated wastewater and sewer overflow |
| Q33655485 | Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans |
| Q47887215 | Effect of cyclooxygenase inhibition on the inspiratory muscle metaboreflex-induced cardiovascular consequences in men. |
| Q50441616 | Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers. |
| Q60679020 | Effect of ibuprofen exposure on blood, gill, liver, and brain on common carp (Cyprinus carpio) using oxidative stress biomarkers |
| Q53625279 | Effects of Zingiber cassumunar (Plai cream) in the treatment of delayed onset muscle soreness. |
| Q44574223 | Effects of absorption rate on the pre-systemic chiral inversion of ibuprofen in rabbits |
| Q38682570 | Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months |
| Q38707717 | Electrospun PLGA Nanofiber Scaffolds Release Ibuprofen Faster and Degrade Slower After In Vivo Implantation. |
| Q45794012 | Enantiomer-specific in vitro biotransformation of select pharmaceuticals in rainbow trout (Oncorhynchus mykiss). |
| Q43961618 | Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor |
| Q80686720 | Enantioselective CE method for pharmacokinetic studies on ibuprofen and its chiral metabolites with reference to genetic polymorphism |
| Q48176246 | Enantioselective analysis of ibuprofen enantiomers in mice plasma and tissues by high-performance liquid chromatography with fluorescence detection: Application to a pharmacokinetic study. |
| Q36061826 | Enantioselective pharmacokinetics of ibuprofen and involved mechanisms |
| Q43553419 | Esophageal laceration and charcoal mediastinum complicating gastric lavage |
| Q39733241 | Explaining the acetaminophen-ibuprofen analgesic interaction using a response surface model. |
| Q60182678 | Farmacogenómica clínica de CYP2C8 y CYP2C9: conceptos generales y aplicación al uso de AINE |
| Q43894484 | Fast and sensitive capillary electrophoresis method to quantitatively monitor ibuprofen enantiomers released from polymeric drug delivery systems |
| Q41922089 | Formulation and delivery strategies of ibuprofen: Challenges and opportunities. |
| Q64949060 | Genotoxic stress induces Sca-1-expressing metastatic mammary cancer cells. |
| Q40655442 | Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics |
| Q38811685 | How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity |
| Q37440655 | Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. |
| Q41483588 | Ibuprofen and ketoprofen potentiate UVA-induced cell death by a photosensitization process. |
| Q39237721 | Ibuprofen blood plasma levels and onset of analgesia |
| Q46650436 | Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations. |
| Q24248782 | Ibuprofen for Alzheimer's disease |
| Q39665168 | Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen |
| Q45248999 | Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models |
| Q73375017 | Ibuprofen-induced liver mitochondrial permeability transition |
| Q42442565 | In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen |
| Q44247766 | In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient |
| Q35825392 | Influence of age on the enantiomeric disposition of ibuprofen in healthy volunteers |
| Q30457751 | Ingestion of low-dose ibuprofen following resistance exercise in postmenopausal women |
| Q35846717 | Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug |
| Q58188406 | Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure |
| Q35803721 | Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use. |
| Q33722871 | Management of lipid disorders |
| Q28168971 | Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers |
| Q47881769 | Melting Process of the Peritectic Mixture of Lidocaine and Ibuprofen Interpreted by Site Percolation Theory Model. |
| Q37304218 | Metabolic profiling and population screening of analgesic usage in nuclear magnetic resonance spectroscopy-based large-scale epidemiologic studies |
| Q53042156 | Microextraction by packed sorbent and HPLC-PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine. |
| Q34683444 | Molecular descriptors that influence the amount of drugs transfer into human breast milk. |
| Q26749687 | Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis |
| Q36847720 | Non-steroidal anti-inflammatory drugs do not influence the urinary testosterone/epitestosterone glucuronide ratio |
| Q89584499 | Nonopioid analgesics for perioperative and cardiac surgery pain in children: Current evidence and knowledge gaps |
| Q46309290 | Nonsteroidal anti-inflammatory drugs do not interfere with imiquimod treatment for usual type vulvar intraepithelial neoplasia |
| Q39306907 | Onset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen--a single-dose, double-blind, placebo-controlled study in patients with post-operative dental pain |
| Q24193261 | Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period |
| Q26471110 | Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period |
| Q90363436 | PETRA: Drug Engineering via Rigidity Analysis |
| Q36148700 | Pain management for dentists: the role of ibuprofen. |
| Q35164718 | PharmGKB summary: ibuprofen pathways. |
| Q36110592 | Pharmacogenetics of analgesic drugs |
| Q38050316 | Pharmacogenetics of nonsteroidal anti-inflammatory drugs |
| Q49496924 | Pharmacokinetic Drug Interaction Study of Bazedoxifene and Ibuprofen. |
| Q64112950 | Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossove |
| Q38388493 | Pharmacokinetic Properties of Intravenous Ibuprofen in Healthy Chinese Volunteers |
| Q41020386 | Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen |
| Q44802428 | Pharmacokinetic interaction of ibuprofen enantiomers in rabbits |
| Q45990596 | Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes. |
| Q40618816 | Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen |
| Q39666861 | Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers |
| Q42694856 | Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers |
| Q35660923 | Pharmacokinetics of Ibuprofen in children with cystic fibrosis |
| Q34252982 | Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. |
| Q40199090 | Pharmacologic, pharmacodynamic, and pharmacokinetic considerations with intravenous Ibuprofen lysine |
| Q34517223 | Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration |
| Q90043510 | Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations |
| Q43905536 | Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: Pharmacokinetic-pharmacodynamic modeling analysis |
| Q46809106 | Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects |
| Q35274875 | Population pharmacokinetics of high dose ibuprofen in cystic fibrosis |
| Q45040965 | Population pharmacokinetics of ibuprofen enantiomers in very premature neonates. |
| Q73277247 | Potential interaction between itraconazole and clarithromycin |
| Q46119650 | Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib. |
| Q62566944 | Prediction of drug bioavailability based on molecular structure |
| Q38827332 | Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs |
| Q28191840 | Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol |
| Q36773723 | Role of racemization in optically active drugs development. |
| Q55449426 | Safety of ibuprofen in infants younger than six months: A retrospective cohort study. |
| Q87791984 | Single- and Multiple-Dose Pharmacokinetics of Immediate-Release/Extended-Release Ibuprofen Tablets |
| Q53296082 | Single-drop microextraction combined in-line with capillary electrophoresis for the determination of nonsteroidal anti-inflammatory drugs in urine samples. |
| Q27025964 | Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury |
| Q48881817 | Standard addition method for the determination of pharmaceutical residues in drinking water by SPE-LC-MS/MS. |
| Q37078332 | Stereoconfiguration of antiallergic and immunologic drugs |
| Q36376111 | Stereoselective binding of human serum albumin. |
| Q35051422 | Stereoselective determination and pharmacokinetics of dihydropyridines: an updated review |
| Q44150756 | Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers |
| Q44633658 | Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum |
| Q42728810 | Study of the extent and rate of bioavailability of ibuprofen tablets |
| Q54482599 | The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation. |
| Q41948835 | The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC |
| Q49614185 | The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation. |
| Q46609012 | The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training |
| Q33625366 | The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol |
| Q35025003 | Timing of Ibuprofen Use and Musculoskeletal Adaptations to Exercise Training in Older Adults |
| Q53103449 | Usefulness of the chaotropic effect in sample preparation for chromatographic analysis of acidic xenobiotics in human plasma. |
Search more.